Smith & Nephew DurafiberAg Gelling Fiber Dressing 4 x 4

What is 5466801174-Box Smith & Nephew DurafiberAg Gelling Fiber Dressing 4 x 4?

The 5466801174-Box Smith & Nephew DurafiberAg Gelling Fiber Dressing 4 x 4 is a sterile, non-adherent wound care solution designed for managing moderate to heavily exuding wounds. Infused with ionic silver, it leverages antimicrobial properties to help reduce bioburden in the wound bed. Upon contact with exudate, the dressing forms a cohesive gel that maintains a moist healing environment, promoting autolytic debridement and supporting granulation tissue formation. Each 4-inch by 4-inch pad is suitable for a variety of acute and chronic wounds, particularly where infection risk is a concern.

Key features

• Silver technology — Releases ionic silver to help control microbial growth in the wound.
• Gelling fibers — Converts to a soft gel to conform to wound contours and manage exudate.
• Non-adherent design — Minimizes trauma during dressing changes.
• Absorptive capacity — Handles moderate to heavy wound drainage effectively.
• Sterile single-use pads — Ensures safety and reduces contamination risk.
• Convenient size — 4 x 4 inch format fits common wound dimensions.
• Compatible with compression — Can be used under compression therapy when needed.

Who is 5466801174-Box Smith & Nephew DurafiberAg Gelling Fiber Dressing 4 x 4 for?

This dressing is ideal for healthcare providers and patients managing infected or critically colonized chronic wounds, including diabetic foot ulcers, pressure injuries, venous leg ulcers, and surgical wounds with infection risk. It’s especially beneficial for individuals with compromised healing due to diabetes or vascular conditions. The antimicrobial action makes it suitable for wounds needing bioburden reduction without systemic antibiotics.

How does 5466801174-Box Smith & Nephew DurafiberAg Gelling Fiber Dressing 4 x 4 compare?

Compared to standard alginate or gelling fiber dressings without silver, DurafiberAg offers added antimicrobial protection, making it more effective in managing infected wounds. It outperforms basic non-silver dressings in bioburden control while maintaining similar exudate management. Unlike foam or hydrocolloid dressings, it provides superior absorption in highly exudative wounds and supports autolytic debridement. It is comparable to other silver-alginate dressings but may offer better gel cohesion and less lateral wicking, reducing periwound maceration risk.